Browse Guides  internal medicine  haematology  anticoagulation

Warfarin

Starting treatment
Indications
Dosing and monitoring
Complications
Follow-up
Follow-up

Arrange for patients to have regular monitoring of INR levels a by any of the following: 
  • self-monitoring d
  • primary-care monitoring d
  • outpatient clinic d 

Advise your patient 

  • about the risk of bleeding, but indicate that serious bleeds are rare b
  • most patients on warfarin feel as healthy as patients who are not a  
  • many drugs and foods interact with warfarin and patients should check that any new medication they take is safe. b  
Monitor patients with the following conditions more carefully - they are at increased risk of having a supratherapeutic INR b  
  • on > 2.5 g of paracetamol a week 
  • recently started warfarin-potentiating medication 
  • taking more warfarin than prescribed 

  • advanced cancer 

  • decreased oral intake in the last week 
  • acute diarrhoeal illness in the last week 

Monitor the following patients closely - they are at increased risk of having a major bleed

  • high therapeutic range  b 
  • supratherapeutic INR ( > 4.5)  a b
  • recently started warfarin  a 

  • old age  a 
  • arterial disease  a 
  • co-morbid conditions  b  (stroke, serious heart, liver or renal disease) 
  • previous GI bleed  a 

  • on NSAIDs   b 
The following features increase the risk of an intracranial bleed: a  
  • supratherapeutic INR ( > 4.0)
  • previous stroke
  • prosthetic heart valves
  • old age 
Around half of intracranial bleeds are fatal, and few patients make a full recovery. a  

Expiry date: May 2003
Levels of Evidence used in grading these guides

With thanks to Drs. David Keeling, John Reynolds, David Sackett, Sharon Straus and Alan Townsend 
for use of their anticoagulation guide on which this one is based.

Author   CM   Ball
Reviewer   A   Gallus
CAT Writer   CM   Ball